Clinic
Rose Bowling, LLC
Rose Bowling, LLC was paid $3.92M by Medicaid between Jan 2018 and Dec 2024, across 49 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 62% of everything it billed.
33Billing provider infoROSE BOWLING, LLC
RICHMOND, KY 40475
RICHMOND, KY 40475
33aNPI1891799177assigned 06/02/2005
33bProvider typeRural Health Clinic/Center
28Total paid$3.92M
24GClaims171,838
24DCodes billed49
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rural Health Clinic/Center providers in Kentucky
Rank by total paid#11 of 265
Median peer was paid$400K
This provider vs. median9.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,988 | $499K | |
| 2019 | 24,149 | $518K | |
| 2020 | 20,513 | $478K | |
| 2021 | 30,010 | $718K | |
| 2022 | 30,759 | $679K | |
| 2023 | 24,866 | $593K | |
| 2024incomplete | 18,553 | $438K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 62% | 85,458 | 60,470 | $2.42M |
| 87428 | 9.2% | 6,954 | 5,827 | $361K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 6.7% | 23,372 | 19,693 | $262K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.6% | 12,387 | 8,351 | $221K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.5% | 1,815 | 1,720 | $99K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.0% | 1,653 | 1,534 | $79K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.8% | 4,176 | 3,546 | $69K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.6% | 5,294 | 4,087 | $64K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.6% | 1,103 | 1,053 | $62K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.2% | 4,195 | 3,874 | $48K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.0% | 2,997 | 2,807 | $40K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,648 | 1,280 | $33K |
37 more codes
| 99441 | <1% | 1,007 | $30K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 354 | $23K |
| 99442 | <1% | 406 | $19K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 372 | $18K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 415 | $14K |
| 87807 | <1% | 1,284 | $13K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 338 | $12K |
| 90473 | <1% | 752 | $8K | |
| 83655 | <1% | 493 | $5K | |
| 85018 | <1% | 1,907 | $3K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,636 | $3K |
| 99383 | <1% | 37 | $2K | |
| 36416 | <1% | 1,920 | $2K | |
| 81003 | <1% | 2,852 | $2K | |
| 90688 | <1% | 112 | $973.67 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 23 | $914.25 |
| 90633 | <1% | 1,489 | $891.16 | |
| 90710 | <1% | 215 | $773.47 | |
| 99382 | <1% | 19 | $741.73 | |
| 90670 | <1% | 1,246 | $722.22 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,138 | $548.43 |
| 81025 | <1% | 66 | $351.61 | |
| 90680 | <1% | 666 | $293.83 | |
| 90648 | <1% | 711 | $232.19 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 29 | $231.84 |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 15 | $192.60 |
| 90723 | <1% | 354 | $97.25 | |
| 90686 | <1% | 404 | $85.91 | |
| 90696 | <1% | 24 | $39.30 | |
| 90734 | <1% | 221 | $38.92 | |
| 90685 | <1% | 32 | $36.24 | |
| 90660 | <1% | 40 | $29.30 | |
| 90715 | <1% | 90 | $0.01 | |
| 90677 | 0% | 30 | $0.00 | |
| 90698 | 0% | 17 | $0.00 | |
| 90649 | 0% | 47 | $0.00 | |
| 888888 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOWLING, REBA (OWNER CEO)